IMHSI is conducting a controlled rat study to evaluate the systemic effects of Mad Honey, with a specific focus on grayanotoxins I (GTX-I) and III (GTX-III) at varying dose levels. This study is foundational to IMHSI’s broader mission of establishing internationally recognised safety standards for Himalayan cliff honey.
The research is designed to generate the dose-response data that is currently absent from the scientific literature — data that regulators, food safety agencies, and export markets need before Mad Honey can be formally recognised within international frameworks such as Codex Alimentarius and EFSA.
Quantified relationships between GTX-I and GTX-III exposure levels and observed physiological and behavioural effects in rats.
Conversion of rat study findings to human-equivalent dose estimates, enabling evidence-based safe consumption threshold recommendations.
Toxicity thresholds and supporting data that can be submitted to international food safety bodies for consideration in regulatory frameworks.
IMHSI welcomes research partnerships with universities, laboratories, and independent toxicologists.
For general enquiries, visit our Contact page.